📣 VC round data is live. Check it out!
- Public Comps
- Medifast
Medifast Valuation Multiples
Discover revenue and EBITDA valuation multiples for Medifast and similar public comparables like Komplett, Bike24, PChome Online, Cash Converters and more.
Medifast Overview
About Medifast
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
Founded
1989
HQ

Employees
380
Website
Financials (LTM)
Market Cap
$145M
Valuation Multiples
Start free trialMedifast Financials
Medifast reported last 12-month revenue of $349M and EBITDA of $4M.
In the same LTM period, Medifast generated $246M in gross profit, $4M in EBITDA, and had net loss of ($18M).
Revenue (LTM)
Medifast P&L
In the most recent fiscal year, Medifast reported revenue of $386M and EBITDA of $8M.
Medifast is unprofitable as of last fiscal year, with gross margin of 71%, EBITDA margin of 2%, and net margin of (5%).
Financial data powered by Morningstar, Inc.
Medifast Stock Performance
Medifast has current market cap of $145M.
Market Cap Evolution
Medifast's stock price is $13.02.
Medifast share price increased by 19.8% in the last 30 days, and decreased by 7.5% in the last year.
Medifast has an EPS (earnings per share) of $-1.68.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $145M | 0.0% | 19.8% | 23.6% | -7.5% | $-1.68 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedifast Valuation Multiples
Medifast trades at (0.0x) EV/Revenue multiple, and (1.9x) EV/EBITDA.
EV / Revenue (LTM)
Medifast Financial Valuation Multiples
As of May 8, 2026, Medifast has market cap of $145M.
Medifast has a P/E ratio of (7.9x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medifast Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Medifast Margins & Growth Rates
Medifast decreased revenue by 27% and EBITDA by 124% in the last fiscal year.
In the most recent fiscal year, Medifast reported gross margin of 71%, EBITDA margin of 2%, and net margin of (5%).
Medifast Margins
Medifast Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Medifast Operational KPIs
Medifast's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.8M for the same period.
Medifast's Rule of 40 is (28%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medifast's Rule of X is (69%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Medifast Competitors
Medifast competitors include Komplett, Bike24, PChome Online, Cash Converters, CLIO Cosmetics, Jade Group, Waldencast, Reckitt Benckiser, Acme United and Global Fashion Group.
Most Medifast public comparables operate across Consumer E-commerce, Health & Beauty, Personal Services and Vertical E-commerce.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.2x | 0.2x | 6.6x | 5.5x | |||
| 0.6x | 0.4x | 76.1x | 7.8x | |||
| 0.3x | — | 27.0x | — | |||
| 1.0x | 0.9x | 5.5x | 5.6x | |||
| 0.3x | — | 4.8x | — | |||
| 1.0x | 1.0x | 10.2x | — | |||
| 0.9x | 0.9x | 12.8x | 11.5x | |||
| 2.7x | — | 11.9x | — | |||
This data is available for Pro users. Sign up to see all Medifast competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medifast
| When was Medifast founded? | Medifast was founded in 1989. |
| Where is Medifast headquartered? | Medifast is headquartered in United States. |
| How many employees does Medifast have? | As of today, Medifast has over 380 employees. |
| Who is the CEO of Medifast? | Medifast's CEO is Daniel R. Chard. |
| Is Medifast publicly listed? | Yes, Medifast is a public company listed on NYSE. |
| What is the stock symbol of Medifast? | Medifast trades under MED ticker. |
| When did Medifast go public? | Medifast went public in 1981. |
| Who are competitors of Medifast? | Medifast main competitors include Komplett, Bike24, PChome Online, Cash Converters, CLIO Cosmetics, Jade Group, Waldencast, Reckitt Benckiser, Acme United, Global Fashion Group. |
| What is the current market cap of Medifast? | Medifast's current market cap is $145M. |
| What is the current revenue of Medifast? | Medifast's last 12 months revenue is $349M. |
| What is the current revenue growth of Medifast? | Medifast revenue growth (NTM/LTM) is (22%). |
| What is the current EV/Revenue multiple of Medifast? | Current revenue multiple of Medifast is (0.0x). |
| Is Medifast profitable? | Yes, Medifast is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Medifast? | Medifast's last 12 months EBITDA is $4M. |
| What is Medifast's EBITDA margin? | Medifast's last 12 months EBITDA margin is 1%. |
| What is the current EV/EBITDA multiple of Medifast? | Current EBITDA multiple of Medifast is (1.9x). |
| What is the current FCF of Medifast? | Medifast's last 12 months FCF is ($3M). |
| What is Medifast's FCF margin? | Medifast's last 12 months FCF margin is (1%). |
| What is the current EV/FCF multiple of Medifast? | Current FCF multiple of Medifast is 2.5x. |
| How many companies Medifast has acquired to date? | Medifast hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Medifast has invested to date? | Medifast hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Medifast
Lists including Medifast
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.